Concepedia

E. K.

EK

Statistics

Publications

4

Citations

280

H-Index

4

Active since

2012

Affiliations

Heidelberg University(Current)

German Cancer Research Center

University Hospital Heidelberg

University Medical Center of the Johannes Gutenberg University Mainz

Johannes Gutenberg University Mainz

E. K. is an author at Heidelberg University specializing in multiple myeloma, medicine, and bortezomib therapy.

Publications per year

2012–2015

4

Publications

4

Phase III trial of bortezomib, cyclophosphamide and dexamethasone (VCD) versus bortezomib, doxorubicin and dexamethasone (PAd) in newly diagnosed myeloma

E. K., Uta Bertsch, Jan Dürig et al. · Leukemia · 2015 · 141 citations

, , +14

Subcutaneous versus intravenous bortezomib in two different induction therapies for newly diagnosed multiple myeloma: an interim analysis from the prospective GMMG-MM5 trial

Maximilian Merz, Hans Salwender, Mathias Haenel et al. · Haematologica · 2015 · 71 citations · Full text

, , +15

A magnetic resonance imaging-based prognostic scoring system to predict outcome in transplant-eligible patients with multiple myeloma

E. K., Thomas Hielscher, J.K. Kloth et al. · Haematologica · 2015 · 51 citations · Full text

, , +16

The Xpert® MTB/RIF assay evaluation in South Korea, a country with an intermediate tuberculosis burden

Su Yeong Kim, Hyun‐Chang Kim, Su Yeong Kim et al. · The International Journal of Tuberculosis and Lung Disease · 2012 · 17 citations

, , +17

1–4 of 4